Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evolus Inc.

9.38
+0.10001.08%
Post-market: 9.35-0.0293-0.31%19:09 EDT
Volume:900.97K
Turnover:8.37M
Market Cap:604.78M
PE:-10.55
High:9.47
Open:9.20
Low:9.13
Close:9.28
Loading ...

BRIEF-Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
14 Jun

Evolus Inc. Announces New Inducement Grants Under 2023 Incentive Plan for Newly Hired Employees

Reuters
·
14 Jun

Mizuho Securities Reaffirms Their Buy Rating on Evolus (EOLS)

TIPRANKS
·
12 Jun

Evolus director buys $189K in common stock

TIPRANKS
·
11 Jun

Director Albert G III White Reports Acquisition of Common Shares in Evolus Inc

Reuters
·
11 Jun

Evolus Inc. Conducted Annual Meeting of Stockholders

Reuters
·
07 Jun

Evolus (EOLS) Receives a Buy from BTIG

TIPRANKS
·
28 May

Evolus CFO Sandra Beaver Resigns

MT Newswires Live
·
28 May

BRIEF-Evolus Announces Departure Of Its Chief Financial Officer

Reuters
·
28 May

Evolus Announces Departure of Its Chief Financial Officer

THOMSON REUTERS
·
28 May

Evolus Inc - CFO Sandra Beaver Resigns Effective June 13, 2025

THOMSON REUTERS
·
28 May

Evolus announces publication of U.S. pivotal study for Evolysse injectable gels

TIPRANKS
·
22 May

Evolus Inc. Announces U.S. Pivotal Study Results Confirming Superiority of New Injectable Hyaluronic Acid Gels for Facial Wrinkle Correction

Reuters
·
22 May

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
17 May

Evolus Inc. Announces New Inducement Grants Under 2023 Incentive Plan for New Employees

Reuters
·
17 May

Evolus Inc. Director and Officer David Moatazedi Reports Disposal of Common Shares

Reuters
·
15 May

Evolus Price Target Maintained With a $22.00/Share by Needham

Dow Jones
·
08 May

Evolus Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Evolus Q1 Sales $68.50M Miss $72.20M Estimate

Benzinga
·
08 May

BRIEF-Evolus Q1 Product Revenue USD 68.074 Million

Reuters
·
08 May